Table 2. Drug-Related Adverse Events*.
Drug-Related Event | All Grades (N = 135) | Grade 3 or 4 (N = 135) |
---|---|---|
number (percent) | ||
Any | 107 (79) | 17 (13) |
| ||
Hypothyroidism | 11 (8) | 1 (1) |
| ||
Gastrointestinal disorder
| ||
Diarrhea | 27 (20) | 1 (1) |
| ||
Nausea | 13 (10) | 0 |
| ||
Abdominal pain | 7 (5) | 1 (1) |
| ||
Generalized symptom
| ||
Fatigue | 41 (30) | 2 (1) |
| ||
Myalgia | 16 (12) | 0 |
| ||
Headache | 14 (10) | 0 |
| ||
Asthenia | 13 (10) | 0 |
| ||
Pyrexia | 10 (7) | 0 |
| ||
Chills | 9 (7) | 0 |
| ||
Decreased appetite | 6 (4) | 1 (1) |
| ||
Increase in aminotransferase level
| ||
AST | 13 (10) | 2 (1) |
| ||
ALT | 11 (8) | 0 |
| ||
Renal failure | 3 (2) | 2 (1) |
| ||
Respiratory disorder
| ||
Cough | 11 (8) | 0 |
| ||
Dyspnea | 6 (4) | 0 |
| ||
Pneumonitis | 6 (4) | 0 |
| ||
Skin disorder
| ||
Rash | 28 (21) | 3 (2) |
| ||
Pruritus | 28 (21) | 1 (1) |
| ||
Vitiligo | 12 (9) | 0 |
Included are drug-related adverse events that occurred in at least five patients or drug-related grade 3 or 4 adverse events that occurred in at least two patients. ALT denotes alanine aminotransferase, and AST aspartate aminotransferase.